Dogwood Therapeutics (DWTX) Amortizatization of Intangibles (2025 - 2026)

Dogwood Therapeutics (DWTX) posted Amortizatization of Intangibles of $16686.0 for Q2 2026, down 0.91% on a QoQ basis from $16839.0 in Q1 2026.

Analysis

Dogwood Therapeutics (DWTX) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Dogwood Therapeutics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $16686.0 in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn	-
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn	600.00 Mn
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn	-
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn	-
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn	-
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn	-
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn	-
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn	-
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn	1.39 Mn
10	Dogwood Therapeutics	65.53 Mn	65.53 Mn	-	16,686.00

Historic Data

Download Data